5-HT4 5-HT4 RECEPTOR AGONIST FOR GASTROPARESIS

摘要

According to the present invention, (4 - {[4- (2,2,2-trifluoroethoxy) -1,2-benzisoxazole-3-yl] -oxy} methyl) piperidine Yl] methyl} tetrahydro-2H-pyran-4-carboxylic acid. More specifically, the present invention relates to a compound having selective 5-HT4 receptor activity that is useful for the treatment of gastroparesis, or for preventing or delaying the onset or progression of gastroparesis.